Aether Bio

company

About

Aether Bio is a developer of machine learning technology used to re-purpose enzymes in order to create a new compound.

  • 11 - 50

Details

Last Funding Type
Seed
Industries
Artificial Intelligence,Machine Learning,Medical
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

Aether Bio is a developer of machine learning technology used to re-purpose enzymes in order to create a new compound. Its technology utilizes machine learning combined with high-throughput robotic laboratories to create an entirely new compound and reinvent the production of previously discovered compounds that enable healthcare institutes to get the chemicals and materials they need that are more cheap and sustainable. The company's proprietary hardware allows massively parallelized experimentation, generating datasets orders of magnitude larger than the competition.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
Aether Bio has raised a total of — in funding over 2 rounds. Their latest funding was raised on Nov 2, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 2, 2021 Seed 1 Detail
Jul 1, 2019 Seed 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Aether Bio is funded by 2 investors. Gaingels and NJF Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Gaingels Seed
NJF Capital Seed